U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264725) titled 'Libyan Multiple Sclerosis Registry Study' on Nov. 23.
Brief Summary: This study aims to understand differences in access to diagnosis and treatment for people with multiple sclerosis (MS) receiving care in Libya. The study uses data from the Libyan Multiple Sclerosis Registry, which collects clinical and treatment information from patients at two tertiary neurology centres. The main focus is to examine how long it takes for patients to receive an MS diagnosis, who has access to high-efficacy disease-modifying therapies, and how these factors relate to disability levels. The results will help identify gaps in MS care within a conflict...